Pröll S, Nothdurft H D
Abteilung für Infektions- und Tropenmedizin der LMU München.
MMW Fortschr Med. 2004 May 13;146(20):51-4.
Hepatitis A and B continue to represent a risk for travelers. Those traveling to tropical countries are usually aware of this risk, while those visiting a Mediterranean country often are not. This investigation presents a destination-related risk assessment and vaccination recommendations for travellers, on the basis of incidences and prevalences of hepatitis A and hepatitis B. For hepatitis B, the WHO classification based on HBsAg prevalence has been selected. For hepatitis A, countries have been categorized as low-, moderate- or high-risk. A comparison of infection risk with the numbers of airline passengers showed that in particular the large number of travelers to Tunisia, Turkey and Egypt, in conjunction with hygienic conditions in those countries, represent a source of imported hepatitis A. With regard to destinations in the Mediterranean and Eastern Europe, too, the risk of contracting hepatitis A or hepatitis B is not always negligible, so that vaccination may need to be recommended.
甲型和乙型肝炎对旅行者来说仍然是一种风险。前往热带国家的旅行者通常意识到这种风险,而前往地中海国家的旅行者往往没有意识到。本调查根据甲型和乙型肝炎的发病率和流行率,为旅行者提供了与目的地相关的风险评估和疫苗接种建议。对于乙型肝炎,选用了基于乙肝表面抗原(HBsAg)流行率的世界卫生组织分类。对于甲型肝炎,已将各国分为低风险、中等风险或高风险类别。将感染风险与航空旅客数量进行比较后发现,特别是前往突尼斯、土耳其和埃及的大量旅行者,再加上这些国家的卫生条件,构成了甲型肝炎输入的一个来源。在地中海地区和东欧的目的地方面,感染甲型或乙型肝炎的风险也并非总是可以忽略不计的,因此可能需要建议接种疫苗。